Bristol-Myers Squibb (BMY) Tops Q3 EPS by 17c, Beats on Revenue, Offers FY22 Revenue Guidance
Go back to Bristol-Myers Squibb (BMY) Tops Q3 EPS by 17c, Beats on Revenue, Offers FY22 Revenue Guidance| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 63.70 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $63.70 | 52 Week High | $77.12 | |||
| Open | $63.70 | 52 Week Low | $49.03 | |||
| Day High | $63.70 | P/E | 41.36 | |||
| Day Low | $63.70 | EPS | $1.54 | |||
| Volume | 565 | |||||
